(Q34654019)

English

Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease (English)

1 reference

Europe PubMed Central

3 August 2017

author name string

Kyle W Sloop

1

1 reference

Europe PubMed Central

3 August 2017

Aaron D Showalter

2

1 reference

Europe PubMed Central

3 August 2017

Amy L Cox

3

1 reference

Europe PubMed Central

3 August 2017

Julia X C Cao

4

1 reference

Europe PubMed Central

3 August 2017

Angela M Siesky

5

1 reference

Europe PubMed Central

3 August 2017

Hong Yan Zhang

6

1 reference

Europe PubMed Central

3 August 2017

Armando R Irizarry

7

1 reference

Europe PubMed Central

3 August 2017

Susan F Murray

8

1 reference

Europe PubMed Central

3 August 2017

Sheri L Booten

9

1 reference

Europe PubMed Central

3 August 2017

Eleftheria A Finger

10

1 reference

Europe PubMed Central

3 August 2017

Robert A McKay

11

1 reference

Europe PubMed Central

3 August 2017

Brett P Monia

12

1 reference

Europe PubMed Central

3 August 2017

Sanjay Bhanot

13

1 reference

Europe PubMed Central

3 August 2017

M Dodson Michael

14

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

3 May 2007

1 reference

Europe PubMed Central

3 August 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

3 August 2017

282

1 reference

Europe PubMed Central

3 August 2017

26

1 reference

Europe PubMed Central

3 August 2017

19113-19121

1 reference

Europe PubMed Central

3 August 2017

Regulation of glucose production by the liver

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Transmembrane topology of human glucose 6-phosphate transporter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

On the involvement of a glucose 6-phosphate transport system in the function of microsomal glucose 6-phosphatase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Recent advances in hepatic glucose 6-phosphatase regulation and function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Prospects for pharmacologic inhibition of hepatic glucose production

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Hepatic glucose production: therapeutic target in type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

The glucose-6-phosphatase system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Correction of glycogen storage disease type 1a in a mouse model by gene therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Calcium activates glucose-6-phosphatase in intact rat hepatic microsomes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Upregulation of hepatic glucose 6-phosphatase gene expression in rats treated with an inhibitor of glucose-6-phosphate translocase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Nuclear magnetic resonance studies of hepatic glucose metabolism in humans.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610759200

21 January 2018

Identifiers

10.1074/JBC.M610759200

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34654019&oldid=1977283050"